Skip to main content

The AMA (American Medical Association) and ASHP (American Society of Health-System Pharmacists) are committed to exploring the potential of pharmacogenomics-based selection, dosing and monitoring of medications to improve health outcomes.

To further clinicians’ understanding of this emerging area of medicine, the AMA and ASHP are developing an informative series of virtually convened and facilitated webinars to evaluate the evidence base, identify and promote current best practices and guidance on the clinical application of pharmacogenomics, and understand the health equity implications of adoption.

The webinars are free and will run in February and March.

Click here for more information and registration.